ARTICLE
Perifolliculitis capitis abscedens et suffodiens (otherwise known as
dissecting folliculitis of the scalp or as dissecting cellulitis of the
scalp or also as Hoffman's disease) is an uncommon, chronic, progressive,
inflammatory, suppurative scalp disorder that almost exclusively affects
Afro-Caribbean males. Spitzer in 1903 first described this entity (under
the title Dermatitis Follicularis et Perifollicularis Conglobata) in association
with severe acne conglobata. The second case report was presented by Nobl,
before the Vienna Dermatological Society October 26, 1904, which fits
into the clinical description of Hoffman's case. Hoffman presented the
next case to the Berlin Dermatological Society on March 12, 1907 and named
the disease perifolliculitis capitis abscedens et suffodiens [1]. It is
a descriptive denomination (suffodiens: latin suffodio to dig under).
Interest in this clinical case presentation arises from the following
data: (a) very few cases of dissecting folliculitis in white patients
have been reported in the literature, (b) clinical features of this entity
as well as the corresponding (to each case) histological picture may vary
from case to case, (c) therapeutic means that have been applied and described
in the literature are limited and frequently disappointing, (d) causes
are unknown. Familial cases have been reported rarely [2, 3], (e) risk
of malignant transformation of Hoffman's disease lesions has already been
recognized [4, 5].
Case report
Our patient was a 20 year-old white male subject, presented at consultation
because he sensed six months ago (and he has since observed) the existence
(on the vertex region of the scalp) of two circumscribed, oval (of 3 cm
in maximal diameter) alopecia plaques, in the central area of which a
monofocal growth hair was left. Very small pustules were observed on the
erythematous and inflammatory surface of these plaques. These alopecia
areas are neighboring and a thin zone of normally growing hair was interposed
between them (Fig. 1).
We ascertained by palpation that very infiltrated and relatively yielding
cystic formations, existed under the baldness plaques. A similar cystic
formation, reminiscent of a sebaceous cyst, was palpated in the left-lateral
area of the nape. The patient had mild microcystic and pustular acne on
the face and the back. Before admission at our consultation, the patient
had been managed by trials including systemic administration of antibiotics
or corticosteroids as well as subcutaneous injection of corticosteroids.
The above treatments had assured mild regression for 20 to 30 days
and afterwards, a relapse (much more inflammatory compared to the preexisting
clinical aspect) occurred.
We ordered repeated bacteriologic, mycologic, mycobacteriologic
and virologic investigations from the scalp lesions (showing no pathological
findings). The exhaustive haematological-biochemical-immunological investigations
as well as the computed tomography of visceral cranium and brain, were normal.
Two biopsies (one on each plaque) have been realized and the relevant histological
studies showed similar findings between them. The development of inflammatory,
granulomatous tissue (with abundance of epithelioid histiocytes and polynuclear
giant cells as of Langerhans' type as of foreign body type) was observed
in the dermis (Figs. 2, 3).
Special stains for bacteria, mycobacteria and fungi were negative. The diagnosis
of dissecting cellulitis of the scalp was verified. A clindamycin gel (1 %)
and an isotretinoin gel (0.05 %) were applied topically on the totality
of the alopecia plaques and after a treatment of two months, the pustules
and the other inflammatory elements disappeared, the cystic infiltration
was reduced dramatically and a diffuse hair growth was observed on half
at least, of the surface of the plaques (Fig.
4). We proposed an isotretinoin systemic administration in order to
ensure a more rapid and impressive therapeutic result but our patient refused
this treatment. Isotretinoin topical application for further eight months,
maintaining the obtained result, was followed by an one year period without
treatment and without relapse.
Discussion
We presented above an 18 year-old male patient of phototype IV. Only
3 patients (among almost 50 cases analytically published in
the literature) [1-23] concern subjects of the white race [10, 16, 21]
(in 4 cases the race of the patients was not elucidated [9, 15, 16,
18] whereas all the other presentations included black patients). The
majority of the patients are male (except 7 female subjects) [7,
11, 14, 15, 19]. First appearance of the disease age varies from 15 to
33 year-old, except one case concerning a lymphoma presenting as
dissecting folliculitis [5]. It is worthwhile to report that the malignant
transformation of the disease to squamous cell carcinoma, has been diagnosed
at the age of 41 year-old (where dissecting folliculitis appeared
19 years previously) [4]. Clinically the disease begins as a folliculitis,
most commonly involving the vertex and/or occipital scalp. This is rapidly
followed by horizontal spreading, abscess, sinus formation and alopecia.
Our patient presented at consultation in this second clinical evolutionary
phase.
The whole process ends up with cicatrization and nodular formation. These
nodules suppurate and spread to form intercommunicating sinuses. These
sinuses, as long as 4 cm to 5 cm, can be easily traced by a
probe. Seropurulent drainage may last indefinitely. The nodular form of
five cases was associated with spontaneous severe pain [4, 10, 22, 23].
Sometimes a swelling of beard area may coexist.
The disease starts with a keratinized occluded follicular orifice. Stasis
in the pilosebaceous apparatus promotes
fertile soil for bacterial multiplication. Folliculitis and perifoculitis
results from follicular occlusion either from immune-immediate chronic
inflammation resulting from hypersensitivity to Propionibacterium acnes
or an immune complex disorder. Secondary infection probably ensues. Staph.
aureus, staph. epidermidis, strept. beta-haemolytic,
pseudomonas aeruginosa and diphtheroid bacilli may be isolated
[4, 7, 8, 11, 12, 15]. However, bacteriologic cultures are usually negative
[13, 18, 20-23].
The younger lesions showed a benign hyperkeratosis
around the follicle orifice, atrophy of the orifice, massive keratotic
plugging and an infiltrate (in the upper dermis) consisting primarily
of neutrophils. Lesions of longer duration had an infiltrate of plasma
cells, histiocytes, lymphocytes in the upper and middle corium. Older
lesions showed predominantly plasma cells [11, 12, 15, 23]. A foreign
body giant cell reaction and granulomatous tissue formation are observed
in the abscess-alopecia second stage of the disease (as seen in our case)
as well as in the nodular-cicatrizant phase. The giant cells frequently
had material in them, which appeared to be keratin. There were changes
of liquefaction degeneration of the collagen and elastic tissue around
the areas of inflammation [4, 6, 7, 9, 14, 15, 21]. Combination with acne
vulgaris is common (in 30 % of the cases). The disease is considered
to be part of the follicular occlusion tetrad, together with acne conglobata,
chronic hidradenitis suppurativa and pilonidal cysts [8, 24]. The central
pathogenic event in all four entities is a tendency toward follicular
hyperkeratosis leading to retention of follicular products with secondary
bacterial infection. The common anatomoclinical features of the follicular
occlusion are the following: formation of multiple comedones, abscesses
with communicating channels, discharging sinuses.
Squamous cell carcinomas may arise within acne conglobata and hidradenitis
suppurativa. One case in which a metastasizing squamous cell carcinoma
developed in a long-standing lesion, has already been reported [4]. An
aggressive large cell variant of folliculotropic mycosis fongoïdes should
be included in the differential diagnosis of dissecting cellulitis of
the scalp, emphasizing the importance of a biopsy in any nonhealing lesion,
to rule out lymphoma [5]. Cutaneous signs of follicular occlusion may
coexist with asymmetric peripheral and axial arthritis [7, 21, 22].
Treatment is varied and generally unsuccessful. Oral antibiotics and oral
zinc have occasionally produced good results [16]. Satisfactory results
using x-ray epilation have been reported but radiation therapy for benign
conditions is avoided because of potential long-term adverse effects [14].
Systemic or intralesional steroids provide only partial relief, moreover
might favor eventual malignant transformation [15, 20]. Oral isotretinoin
is effective, although it needs to be continued for 4 months after
clinical control is achieved, to prevent relapse [2, 16, 17, 22, 23].
Oral isotretinoin has been proven sufficiently efficacious as monotherapy
[23], in the abscess-alopecia second stage whereas oral antibiotics and/or
systemic (or intralesional) steroids have been required (as combination
therapy with POs retinoids) in the nodular-scarring third stage of the
disease [22]. A surgical approach may be employed in resistant nodular
cases. The lesions are incised and drained. It is possible to pass a probe
through burrows of interconnecting pustular nodules. Intercommunicating
sinuses should be marsupialized and the surface is cauterized to destroy
the epithelium lining the sinuses [18]. Removal of the entire scalp with
subsequent grafting has been published [12].
CONCLUSION
In our case the topical isotretinoin and clindamycin blocked the disease
in its second phase and thus inhibited the evolution to scarring and nodular
stage. Clindamycin has antibacterial and antiinflammatory action [25].
Topical isotretinoin (as well as the topical retinoic acid or the adapalene)
is characterized by antiinflammatory activity as well as desquamative
and keratolytic action at the follicle infundibulum. Hair regrowth was
eventually favored by the inhibitory retinoid action concerning the enzymatic
5a-reductase activity [26, 27]. Therefore as already supposed in hidradenitis
suppurativa [28, 29], hormonal etiopathogenetic mechanisms are suspected
in dissecting folliculitis and have to be looked for in the future. Moreover
continuous isotretinoin topical application might protect from eventual
malignant transformation [30].
Article accepted on 23/12/2002REFERENCES
1 - Hoffman E. Perifolliculitis capitis abscedens et suffodiens: Case
Presentation. Dermat Ztschr 1908; 16: 122-3.
2 - Bjellerup M, Wallengren J. Familial perifolliculitis capitis abscedens
et suffodiens in two brothers successfully treated with isotretinoin.
J Am Acad Dermatol 1990; 23: 752-3.
3 - Ramesh V. Dissecting cellulitis of the scalp in 2 girls. Dermatologica
1990; 180: 48-50.
4 - Curry SS, Gaither DH, King LE. Squamous cell carcinoma arising in
dissecting perifolliculitis of the scalp. J Am Acad Dermatol
1981; 4: 673-8.
5 - Gilliam AC, Lessin SR, Wilson DM, Salhany KE. Folliculotropic mycosis
fungoides with large-cell transformation presenting as dissecting cellulitis
of the scalp. J Cutan Pathol 1997; 24: 169-75.
6 - Cannon AB. Perifolliculitis capitis abscedens et suffodiens: Case
Presentation. Arch Dermat Syph 1944; 49: 67-8.
7 - Wasserman E. Perifolliculitis Capitis Abscedens et Suffodiens with
Pheumatoid Athritis. AMA Arch Dermat Syph 1951; 64: 787-9.
8 - Kierland RR. Unusual pyodermas (hidrosadenitis suppurativa, acne
conglobata, dissecting cellulitis of the scalp). A review. Minn Med
1951; 34: 319-41.
9 - Reynaers H. Folliculites et Perifolliculites abcedantes de Hoffmann
(AcnE Conglobata du Cuir Chevelu). Arch Belg Dermatol 1954; 10:
42-4.
10 - Gasner WG. Perifolliculitis Capitis Abscedens et Suffodiens:Report
of a Case and Response to Therapy. New York J Med 1957; 57: 947-8.
11 - Moyer DG, Williams RM. Perifolliculitis capitis abscedens et suffodiens.
A Report of six Cases. Arch Dermatol 1962; 85: 118-24.
12 - Moschella SL, Klein MH, Miller RJ. Perifolliculitis Capitis Abscedens
et Suffodiens. Report of a successful therapeutic scalping. Arch
Dermatol 1967; 96: 195-7.
13 - Kumar PP, Henschke UK, Kovi J. Perifolliculitis capitis abscedens
et suffodiens. JAMA 1976; 68 (1): 9-13.
14 - Adrian RM, Arndt KA. Perifolliculitis capitis: Successful Control
with Alternate-Day Corticosteroids. Ann Plast Surg 1980; 4 (2):
166-9.
15 - Berne B, Venge P, Ohman S. Perifolliculitis capitis abscedens et
suffodiens (Hoffman). Arch Dermatol 1985; 121: 1028-30.
16 - Schewach-Millet M, Ziv R, Shapira D. Perifolliculitis capitis abscedens
et suffodiens treated with isotretinoin. J Am Acad Dermatol 1986;
6: 1291-2.
17 - Taylor AEM. Dissecting cellulitis of the scalp: Response to isotretinoin.
Lancet 1987; 25: 225.
18 - Glass IF, Berman B, Laud D. Treatment of perifolliculitis capitis
abscedens et suffodiens with the carbon dioxide laser. J Dermatol
Surg Oncol 1989; 15: 673-6.
19 - Benvenuto MF, Rebora A. Fluctuant nodules and alopecia of the scalp.
Perifolliculitis capitis abscedens et suffodiens. Arch Dermatol
1992; 128: 1118-9.
20 - Shaffer N, Billick RC, Srolovitz H. Perifolliculitis capitis abscedens
et suffodiens. Resolution with combination therapy. Arch Dermatol
1992; 12: 1329-31.
21 - Olafsson S, Khan MA. Musculoskeletal features of acne, hidradenitis
suppurativa and dissecting cellulitis of the scalp. Rheum Dis Clin
North Am 1992; 18: 215-22.
22 - Dyall-Smith D. Signs, syndromes and diagnoses in Dermatology: Dissecting
cellulitis of the scalp. Austral J Dermatol 1993; 34: 81-2.
23 - Scerri L, Williams HC, Allen BR. Dissecting cellulitis of the scalp:
response to isotretinoin. Br J Dermatol 1996; 134: 1105-8.
24 - Pillsbury DM. Bacterial infections of the skin. In: Pillsbury
DM, Shelley WE, Kligman AE, eds. Dermatology, Philadelphia. W.B.
Saunders Co; 1956: 481-3.
25 - Eady EA, Jones CE, Vyarkman S, Cove JF, Cunliffe WJ. Increasing
prevalence of antibiotic resistant propionibacteria on the skin of acne
patients. Results of a five years study. Br J Dermatol 1997;
137 (suppl. 50): 27-8.
26 - Gomez E. Actions of isotretinoin and etretinate on the pilosebaceous
unit. J Am Acad Dermatol 1982; 6 (suppl. 4): 746-50.
27 - Leyden JJ, McGinley K. Effects of 13-cis-retinoic acid on sebum
production and Propionibacterium acnes in severe nodulocystic acne.
Arch Dermatol Res 1982; 272: 331-7.
28 - Ebling FJG. Hidradenitis suppurativa:an androgen-dependent disorder.
Br J Dermatol 1986; 115: 259-62.
29 - Stellon AJ, Wakeling M. Hidradenitis suppurativa associated with
use of oral contraceptive. Br Med J 1989; 298: 28-9.
30 - Frey JR, Peck R, Bollag W. Antiproliferative activity of retinoids,
interferon alpha and their combination in five human transformed cell
lines. Cancer Lett 1991; 57: 223-7.
|